Patent · US Active

Antibodies specifically binding to HER3

US10179815B2 · kind B2 · utility

0Cited by

6References

20Claims

0Family size

Assignees

Ventana Medical Systems, Inc. · US
Roche Molecular Systems, Inc. · US

Inventors

Monika Soukupova · Wessobrunn, DE
Michael Schraeml · Penzberg, DE
Birgit Bossenmaier · Hanerau-Hademarschen, DE
Patrick Roche · Tullow, IE
Michael Gerg · Munich, DE
Sebastian Dziadek · Basel, CH

Key dates

Filing date	Mar 29, 2016
Grant date	Jan 15, 2019
Priority date	—
Expiry date	Mar 29, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/71
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to isolated antibodies, or an antigen portions thereof, which bind to human HER3. The novel antibodies are of great utility since they allow for the sensitive and specific detection of human HER3. Detection of human HER3 is, e.g., possible in a tissue sample, even when such tissue sample is a formalin-fixed paraffin embedded tissue (FFPET) sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.